Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026
Business Wire•08/10/2026•08:00 ET
0
Key Highlights
- ➤Lantern Pharma (LTRN) to present at ThinkEquity Conference October 15, 2026
- ➤Management will hold one-on-one investor meetings throughout the conference
- ➤Pipeline includes LP-300, LP-184, and LP-284 clinical-stage drug programs
- ➤RADR AI platform integrates multi-omic biomarker data with clinical outcomes
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR(®) AI and machine learning (“ML”) platform with multiple clinical stage drug programs, today announced that Lantern management will be presenting at the ThinkEquity Conference on Thursday, October 15, 2026, at 3:30 p.m. ET at the Mandarin Oriental in New York, NY.
Get started
Create a free account to read the full story.